Publication:
[COVID-19 vaccine and anticoagulation patients at high cardiovascular risk. SEMERGEN recommendations].

dc.contributor.authorPallarés-Carratalá, V
dc.contributor.authorPolo García, J
dc.contributor.authorMartín Rioboo, E
dc.contributor.authorRuíz García, A
dc.contributor.authorSerrano-Cumplido, A
dc.contributor.authorBarrios, V
dc.contributor.authoren nombre del Grupo de trabajo de Hipertensión y Enfermedad Cardiovascular de SEMERGEN
dc.date.accessioned2023-02-09T10:40:08Z
dc.date.available2023-02-09T10:40:08Z
dc.date.issued2021-01-02
dc.identifier.doi10.1016/j.semerg.2020.12.005
dc.identifier.essn1578-8865
dc.identifier.pmcPMC7832064
dc.identifier.pmid33478841
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832064/pdf
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.semerg.2020.12.005
dc.identifier.urihttp://hdl.handle.net/10668/17018
dc.issue.number1
dc.journal.titleSemergen
dc.journal.titleabbreviationSemergen
dc.language.isoes
dc.organizationCórdoba
dc.page.number1-3
dc.pubmedtypeEditorial
dc.pubmedtypeComment
dc.rights.accessRightsopen access
dc.subject.meshAnticoagulants
dc.subject.meshBNT162 Vaccine
dc.subject.meshCOVID-19
dc.subject.meshCOVID-19 Vaccines
dc.subject.meshCardiovascular Diseases
dc.subject.meshHeart Disease Risk Factors
dc.subject.meshHumans
dc.subject.meshRNA, Messenger
dc.subject.meshRisk Factors
dc.subject.meshSARS-CoV-2
dc.title[COVID-19 vaccine and anticoagulation patients at high cardiovascular risk. SEMERGEN recommendations].
dc.title.alternativeVacuna COVID-19 y pacientes anticoagulados por alto riesgo cardiovascular. Recomendaciones SEMERGEN.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number47
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC7832064.pdf
Size:
319.07 KB
Format:
Adobe Portable Document Format